retatrutide triple hormone receptor agonist metabolic Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Triple hormone receptor agonist retatrutide

Retatrutide adds glucagon receptor activity on top of those two, and the trend across trials is that each added receptor target is associated with greater average weight loss

And it has profound effects on liver fat, reducing hepatic steatosis by up to 86% in clinical trials

GLP-1 medications work best when combined with: High-protein diet Strength training Walking or aerobic exercise Good sleep Stress management The medication supports your effortsit does not replace healthy habits

Both are manageable

Patients who would like a broader comparison of the active ingredient groups can find an overview on the hub page active ingredients in weight loss medications